Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins

Clin Case Rep. 2022 Aug 3;10(8):e6122. doi: 10.1002/ccr3.6122. eCollection 2022 Aug.

Abstract

Arndt-Gottron (S-AG) syndrome or scleromyxedema is a scarce disease characterized by a generalized papular and sclerodermoid eruption and systemic manifestations that can lead to significant morbid-mortality. Interesting, S-AG can be associated with a paraprotein. We report an exceptional scleromyxedema case associated with a benign monoclonal gammapathy in an old woman.

Keywords: Arndt‐Gottron syndrome; monoclonal gammapathy; scleromyxedema; treatment.

Publication types

  • Case Reports